Login
Search
Search
0 Dates
2026
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
CPC 2026
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Transcatheter versus Surgical Aortic Valve Replacement in Bicuspid Aortic Stenosis: Baseline Characteristics and Early Clinical Outcomes
Session:
Sessão de Posters 31 - Intervenção transcateter na válvula aórtica: acesso, futilidade e anatomia complexa
Speaker:
Catarina Santos-Jorge
Congress:
CPC 2026
Topic:
H. Interventional Cardiology and Cardiovascular Surgery
Theme:
25. Interventional Cardiology
Subtheme:
25.3 Non-coronary Cardiac Intervention
Session Type:
Posters Eletrónicos
FP Number:
---
Authors:
C. Santos-Jorge; Débora da Silva Correia; Rita Barbosa Sousa; Márcia Presume; Márcio Madeira; Tiago Nolasco; Luis Raposo; Afonso Félix de Oliveira; Eduardo Infante Oliveira; João Brito; Rui Campante Teles; Manuel Almeida
Abstract
<p style="text-align:start"><span style="font-size:medium"><span style="font-family:Aptos,sans-serif"><span style="color:#000000"><u>Background</u></span></span></span></p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Aptos,sans-serif"><span style="color:#000000">Transcatheter aortic valve implantation (TAVI) has become a less invasive alternative to surgical aortic valve replacement (SAVR) for severe aortic stenosis, particularly in elderly or high-risk patients. This study aimed to assess clinical characteristics, procedural performance, and early outcomes of TAVI versus SAVR in patients with bicuspid aortic valve stenosis.</span></span></span></p> <p style="text-align:start"> </p> <p style="text-align:start"><span style="font-size:medium"><span style="font-family:Aptos,sans-serif"><span style="color:#000000"><u>Methods</u></span></span></span></p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Aptos,sans-serif"><span style="color:#000000">A retrospective, single-center analysis included 118 consecutive patients treated between 2015 and 2017: 70 undergoing TAVI and 48 SAVR. Baseline demographics, imaging data, periprocedural complications, and early outcomes were compared.</span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Aptos,sans-serif"><span style="color:#000000"><u>Results</u></span></span></span></p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Aptos,sans-serif"><span style="color:#000000">TAVI patients were older (81.4±4.4 vs. 73.2±11.2 years, p<0.001) and had more comorbidities, including chronic kidney disease (84% vs. 31%, p<0.001), chronic pulmonary disease (13% vs. 0%, p=0.010), and permanent atrial fibrillation (19% vs. 2.1%, p=0.023). They showed higher surgical risk (EuroSCORE 3.31 [2.3–4.1] vs. 1.74 [1.3–2.8], p<0.001), lower hemoglobin (12.6 [11.6–13.8] vs. 14 [12.5–14.5] g/dL, p=0.001), and higher NT-proBNP (1570 [659–4462] vs. 459 [193–1474] pg/mL, p=0.008). LVEF was lower in TAVI (55 [51–60] vs. 65 [55–65], p<0.001) and AVA smaller (0.62 [0.5–0.8] vs. 0.7 [0.6–0.9] cm², p=0.027). Technical success at the end of the procedure was high and comparable between groups (TAVI 95.7% vs. SAVR 89.6%, p = 0.193). Similarly, device success at 30 days did not differ significantly (TAVI 75.7% vs. SAVR 79.2%, p = 0.239). However, moderate-to-severe paravalvular leak (15.9% vs. 0%, p=0.004), complete atrioventricular block (21.4% vs. 2.1%, p=0.009), and pacemaker implantation (22.9% vs. 6.3%, p=0.016) occurred more frequently in the TAVI cohort. No significant differences were observed in stroke (2.9% vs. 0%, p=0.238) or in-hospital mortality (4,3% vs. 0%, p=0.150).</span></span></span></p> <p style="text-align:justify"> </p> <p style="text-align:justify"><span style="font-size:medium"><span style="font-family:Aptos,sans-serif"><span style="color:#000000"><u>Conclusions</u></span></span></span></p> <p><span style="font-size:12pt"><span style="color:#000000"><span style="font-family:Aptos,sans-serif">Compared with SAVR, TAVI patients were older, had greater comorbidity and risk scores, and achieved high procedural success with shorter hospitalization, albeit with higher rates of conduction disturbances and paravalvular leak.</span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site